Change in Preferred Drug List Status for the Antiemetic-Antivertigo Agents, Drug Class, Effective Jan. 15, 2025

Published on

HHSC removed the non-preferred status from the generic scopolamine patch products on the preferred drug list (PDL) effective Jan. 15, 2025, in response to the distribution delays for patch products with the preferred brand name Transderm-Scopolamine. Providers can prescribe the generic scopolamine patches without requiring a PDL prior authorization, allowing clients to continue accessing necessary medication. The following table lists the generic scopolamine products with their National Drug Codes (NDCs).

NDCDrug Name
00378647044SCOPOLAMINE 1 MG/3 DAY PATCH
00378647097SCOPOLAMINE 1 MG/3 DAY PATCH
00378647099SCOPOLAMINE 1 MG/3 DAY PATCH
00591225804SCOPOLAMINE 1 MG/3 DAY PATCH
00591225823SCOPOLAMINE 1 MG/3 DAY PATCH
00591225879SCOPOLAMINE 1 MG/3 DAY PATCH
45802058046SCOPOLAMINE 1 MG/3 DAY PATCH
45802058062SCOPOLAMINE 1 MG/3 DAY PATCH
45802058084SCOPOLAMINE 1 MG/3 DAY PATCH
50742050504SCOPOLAMINE 1 MG/3 DAY PATCH
50742050510SCOPOLAMINE 1 MG/3 DAY PATCH
50742050524SCOPOLAMINE 1 MG/3 DAY PATCH